SIGGF (Sigma Healthcare) EBIT: $387 Mil (TTM As of Dec. 2025)


SIGGF Sigma Healthcare Ltd SIGGF
59 GF Score
Price $2.35
GF Value $0.31
! 8 Warning Signs
View Full Analysis

What is Sigma Healthcare EBIT?

Sigma Healthcare SIGGF 59 EBIT is $387 Mil as of Dec. 2025. GuruFocus rates SIGGF with a GF Score™ of 59/100 and a GF Value™ of $0.31. The stock has 8 warning signs investors should review.

Sigma Healthcare's earnings before interest and taxes (EBIT) for the six months ended in Dec. 2025 was $375 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Dec. 2025 was $387 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. Sigma Healthcare's annualized ROC % for the quarter that ended in Dec. 2025 was 12.64%. Sigma Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 86.76%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. Sigma Healthcare's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2025 was 1.65%.


Sigma Healthcare  (OTCPK:SIGGF) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

Sigma Healthcare's annualized ROC % for the quarter that ended in Dec. 2025 is calculated as:

ROC % (Q: Dec. 2025 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jan. 2025 ) + Invested Capital (Q: Dec. 2025 ))/ count )
=373.478 * ( 1 - 29.41% )/( (-533.243 + 4704.554)/ 2 )
=263.6381202/2085.6555
=12.64 %

where

Invested Capital(Q: Dec. 2025 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=5805.536 - 992.587 - ( 108.395 - max(0, 1325.367 - 2209.199+108.395))
=4704.554

Note: The Operating Income data used here is two times the semi-annual (Dec. 2025) data.

2. Joel Greenblatt's definition of Return on Capital:

Sigma Healthcare's annualized ROC (Joel Greenblatt) % for the quarter that ended in Dec. 2025 is calculated as:

ROC (Joel Greenblatt) %(Q: Dec. 2025 )
=EBIT/Average of (Net fixed Assets + Net Working Capital)
=EBIT/Average of (Property, Plant and Equipment+Net Working Capital)
     Q: Jan. 2025  Q: Dec. 2025
=EBIT/( ( (Property, Plant and Equipment + Net Working Capital) + (Property, Plant and Equipment + Net Working Capital) )/ count )
=750.358/( ( (159.592 + max(286.794, 0)) + (374.435 + max(908.819, 0)) )/ 2 )
=750.358/( ( 446.386 + 1283.254 )/ 2 )
=750.358/864.82
=86.76 %

where Working Capital is:

Working Capital(Q: Jan. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(578.936 + 238.902 + 0) - (524.163 + 0.728 + 6.153)
=286.794

Working Capital(Q: Dec. 2025 )
=(Accounts Receivable + Total Inventories + Other Current Assets) - (Accounts Payable & Accrued Expense + Defer. Rev. + Other Current Liabilities)
=(1323.5 + 740.383 + 36.921) - (992.587 + 151.821 + 47.577)
=908.819

When net working capital is negative, 0 is used.

Note: The EBIT data used here is two times the semi-annual (Dec. 2025) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

Sigma Healthcare's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %=EBIT (TTM)/Enterprise Value (Q: Dec. 2025 )
=387.021/23403.788
=1.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Sigma Healthcare EBIT Related Terms


Sigma Healthcare EBIT Historical Data

* Premium members only.

The historical data trend for Sigma Healthcare's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Sigma Healthcare EBIT Chart

Sigma Healthcare Annual Data
Trend Jan16 Jan17 Jan18 Jan19 Jan20 Jan21 Jan22 Jan23 Jan24 Jan25
EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only 49.13 1.82 13.82 16.54 18.48

Sigma Healthcare Semi-Annual Data
Jan16 Jul16 Jan17 Jul17 Jan18 Jul18 Jan19 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Dec25
EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 13.20 3.55 7.11 11.84 375.18

SIGGF vs MCK, COR, CAH: EBIT Comparison

For the Medical Distribution subindustry, Sigma Healthcare's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Sigma Healthcare EV-to-EBIT vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Sigma Healthcare's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Sigma Healthcare's EV-to-EBIT falls into.


SIGGF
59GF Score
Sigma Healthcare Ltd SIGGF
EBIT is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Sigma Healthcare EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

EBIT for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $387 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBIT →
What does a EBIT of $387 Mil mean?
Sigma Healthcare (SIGGF) has a EBIT of $387 Mil as of Dec. 2025. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Sigma Healthcare.
Is Sigma Healthcare's EBIT too high?
Sigma Healthcare's current EBIT is $387 Mil. Overall, Sigma Healthcare has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Sigma Healthcare's EBIT compare to MCK and COR?
Sigma Healthcare's EBIT of $387 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT for a Medical Distribution company?
A good EBIT depends on the Medical Distribution industry context. However, EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT mean?
A high EBIT can signal that a stock is expensive relative to its fundamentals. Earnings before interest and taxes is the difference between operating revenue and operating expenses. View historical data on Sigma Healthcare. Sigma Healthcare's current EBIT is $387 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sigma Healthcare stock overvalued right now?
Sigma Healthcare (SIGGF) has a current EBIT of $387 Mil. The stock's GF Value™ is $0.31, compared to a current price of $2.35 — trading 657.4% above its estimated fair value. The current EBIT is $387 Mil. Sigma Healthcare's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT calculated?
EBIT is calculated from a company's financial statements. For Sigma Healthcare (SIGGF), the current EBIT is $387 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Sigma Healthcare (SIGGF) Overvalued in 2026?

Based on GuruFocus' analysis, Sigma Healthcare stock appears to be overvalued. The current stock price of $2.35 is trading 657.4% above its estimated GF Value™ of $0.31.

Key valuation signals for SIGGF:

  • EBIT: $387 Mil
  • GF Value™: $0.31 vs. price of $2.35 (657.4% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the SIGGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Sigma Healthcare Business Description

Other Exchanges SIG:Australia
Address 6 Albert Street, Preston, VIC, AUS, 3072
Sigma Healthcare is Australia's largest retail pharmacy franchisor, most notably owning the Chemist Warehouse brand, which it merged with in 2025. Sigma is also Australia's largest full-line wholesaler to franchised and independent pharmacies and distributes a broad range of pharmacy products, including prescription medicines, over-the-counter products, and front of store, or FOS, products, at low prices. The group also operates in New Zealand, Ireland, China, and Dubai, has a growing private label range, and offers third-party logistics services.
59GF Score

Get the complete analysis for SIGGF

EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.35
Price
$0.31
GF Value